Correction: The inflammatory marker SIRI acts as a statistical mediator between ApoB/ApoA1 ratio and atrial fibrillation, and combined biomarkers show higher discriminative ability for the presence of atrial fibrillation than single indicators - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The inflammatory marker SIRI serves as a statistical mediator linking the ApoB/ApoA1 ratio to atrial fibrillation, with combined biomarkers demonstrating superior discriminative power for atrial fibrillation compared to individual markers.

  • By

  • Chenyang Zheng

  • Meixue Jia

  • Bin Ning

  • September 2, 2026

Share

  • 1

    The inflammatory marker SIRI mediates the relationship between the ApoB/ApoA1 ratio and atrial fibrillation.

  • 2

    Combined biomarkers demonstrate superior discriminative power for atrial fibrillation compared to individual markers.

  • 3

    The correction addresses an error in the Data Availability statement of the original article.

  • 4

    The correct Data Availability statement indicates that original contributions are contained within the article.

  • 5

    Inquiries regarding the study can be directed to the corresponding authors.

Original Source(s)

Correction: The inflammatory marker SIRI acts as a statistical mediator between ApoB/ApoA1 ratio and atrial fibrillation, and combined biomarkers show higher discriminative ability for the presence of atrial fibrillation than single indicators

  • by Chenyang Zheng, Meixue Jia, Bin Ning

  • September 2, 2026

Related Content

Tirzepatide’s cardiovascular effects in clinical practice

Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.

Maternal Body Mass Index, Gestational Weight Gain, and Cardiovascular Disease in Offspring

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.